scholarly journals Discovery of candidate DNA methylation cancer driver genes

2021 ◽  
pp. candisc.1334.2020
Author(s):  
Heng Pan ◽  
Loic Renaud ◽  
Ronan Chaligne ◽  
Johannes Bloehdorn ◽  
Eugen Tausch ◽  
...  
Author(s):  
Xing Hua ◽  
Wei Zhao ◽  
Angela C. Pesatori ◽  
Dario Consonni ◽  
Neil E. Caporaso ◽  
...  

AbstractIntratumor heterogeneity (ITH) of genomic alterations may impact prognosis of lung adenocarcinoma (LUAD). We investigated ITH of somatic copy number alterations (SCNAs), DNA methylation, and point mutations in lung cancer driver genes in 292 tumor samples from 84 LUAD patients. We found substantial SCNA and methylation ITH, and clonal architecture analyses showed congruent evolutionary trajectories for SCNAs and DNA methylation aberrations. Interestingly, methylation ITH mapping to gene promoter areas or tumor suppressor genes was low. Moreover, ITH composed of genetic and epigenetic mechanisms altering the same cancer driver genes was found in several tumors. To quantify ITH for valid statistical association analyses we developed an average pairwise ITH index (APITH), which does not depend on the number of samples per tumor. APITH indexes for SCNAs and methylation aberrations were both significantly associated with poor prognosis. This study further establishes the important clinical implications of genetic and epigenetic ITH in LUAD.


2021 ◽  
Vol 22 (1) ◽  
Author(s):  
Ege Ülgen ◽  
O. Uğur Sezerman

Abstract Background Cancer develops due to “driver” alterations. Numerous approaches exist for predicting cancer drivers from cohort-scale genomics data. However, methods for personalized analysis of driver genes are underdeveloped. In this study, we developed a novel personalized/batch analysis approach for driver gene prioritization utilizing somatic genomics data, called driveR. Results Combining genomics information and prior biological knowledge, driveR accurately prioritizes cancer driver genes via a multi-task learning model. Testing on 28 different datasets, this study demonstrates that driveR performs adequately, achieving a median AUC of 0.684 (range 0.651–0.861) on the 28 batch analysis test datasets, and a median AUC of 0.773 (range 0–1) on the 5157 personalized analysis test samples. Moreover, it outperforms existing approaches, achieving a significantly higher median AUC than all of MutSigCV (Wilcoxon rank-sum test p < 0.001), DriverNet (p < 0.001), OncodriveFML (p < 0.001) and MutPanning (p < 0.001) on batch analysis test datasets, and a significantly higher median AUC than DawnRank (p < 0.001) and PRODIGY (p < 0.001) on personalized analysis datasets. Conclusions This study demonstrates that the proposed method is an accurate and easy-to-utilize approach for prioritizing driver genes in cancer genomes in personalized or batch analyses. driveR is available on CRAN: https://cran.r-project.org/package=driveR.


EBioMedicine ◽  
2018 ◽  
Vol 27 ◽  
pp. 156-166 ◽  
Author(s):  
Magali Champion ◽  
Kevin Brennan ◽  
Tom Croonenborghs ◽  
Andrew J. Gentles ◽  
Nathalie Pochet ◽  
...  

2013 ◽  
Vol 3 (1) ◽  
Author(s):  
David Tamborero ◽  
Abel Gonzalez-Perez ◽  
Christian Perez-Llamas ◽  
Jordi Deu-Pons ◽  
Cyriac Kandoth ◽  
...  

Oral Oncology ◽  
2020 ◽  
Vol 104 ◽  
pp. 104614 ◽  
Author(s):  
Neil Mundi ◽  
Farhad Ghasemi ◽  
Peter Y.F. Zeng ◽  
Stephenie D. Prokopec ◽  
Krupal Patel ◽  
...  

Cancers ◽  
2020 ◽  
Vol 12 (11) ◽  
pp. 3411
Author(s):  
Laura Pignata ◽  
Orazio Palumbo ◽  
Flavia Cerrato ◽  
Basilia Acurzio ◽  
Enrique de Álava ◽  
...  

The embryonal renal cancer Wilms tumor (WT) accounts for 7% of all children’s malignancies. Its most frequent molecular defect is represented by DNA methylation abnormalities at the imprinted 11p15.5 region. Multiple imprinted methylation alterations dictated by chromosome copy-number variations have been recently demonstrated in adult cancers, raising the question of whether multiple imprinted loci were also affected in WT. To address this issue, we analyzed DNA methylation and chromosome profiles of 7 imprinted loci in 48 WT samples. The results demonstrated that methylation abnormalities of multiple imprinted loci occurred in 35% of the cases, but that they were associated with either chromosome aberrations or normal chromosome profiles. Multiple imprinted methylation changes were correlated with tumor stage and presence of metastasis, indicating that these epimutations were more frequent in highly aggressive tumors. When chromosome profiles were affected, these alterations were extended to flanking cancer driver genes. Overall, this study demonstrates the presence of multiple imprinted methylation defects in aggressive WTs and suggests that the mechanism by which they arise in embryonal and adult cancers is different.


Sign in / Sign up

Export Citation Format

Share Document